Valuation Morepen Laboratories Limited

Stocks

Market Closed - Bombay S.E. 13:23:40 11/09/2026 +03			5-day change	1st Jan Change
115.95 ^INR	+0.69%		+1.98%	+182.32%

08-05	Morepen Laboratories Limited announces Annual dividend, payable on October 26, 2026	CI
08-04	Morepen Laboratories Limited Reports Earnings Results for the First Quarter Ended June 30, 2026	CI

Data adjusted to current consolidation scope

Fiscal Period: March	2021	2022	2023	2024	2025	2026
Market Cap ¹	14,462	17,488	13,127	21,500	26,220	18,521
Change	-	20.93%	-24.94%	63.79%	21.95%	-29.36%
Enterprise Value (EV) ¹	15,415	18,663	13,162	21,620	26,219	20,059
Change	-	21.07%	-29.48%	64.27%	21.27%	-23.49%
P/E	15x	18.7x	33.4x	22.4x	21.8x	19.5x
PBR	3.4x	3.02x	1.74x	2.54x	2.27x	1.49x
PEG	-	-2.12x	-0.6x	0x	1.3x	-0.9x
Capitalization / Revenue	1.21x	1.12x	0.92x	1.26x	1.45x	1.03x
EV / Revenue	1.29x	1.2x	0.93x	1.27x	1.45x	1.11x
EV / EBITDA	12.5x	13.9x	19.2x	14x	16.2x	18.2x
EV / EBIT	15.7x	15.8x	23.5x	15.8x	18.1x	22.5x
EV / FCF	-54.9x	-13x	-47.9x	-94x	-11.8x	-13.5x
FCF Yield	-1.82%	-7.71%	-2.09%	-1.06%	-8.51%	-7.39%
Dividend per Share ²	-	-	-	-	0.2	0.2
Rate of return	-	-	-	-	0.42%	0.59%
EPS ²	2.15	1.96	0.77	1.88	2.2	1.731
Distribution rate	-	-	-	-	9.09%	11.6%
Net sales ¹	11,980	15,558	14,220	17,019	18,116	18,057
EBITDA ¹	1,230	1,338	686.6	1,545	1,620	1,101
EBIT ¹	981.7	1,180	560.8	1,366	1,451	891.9
Net income ¹	970.9	1,017	386.8	961.6	1,180	948.8
Net Debt ¹	953.1	1,174	34.98	120.5	-0.928	1,538
Reference price ²	32.15	36.60	25.68	42.06	47.85	33.80
Nbr of stocks (in thousands)	449,826	477,826	511,169	511,169	547,954	547,954
Announcement Date	9/4/21 A	9/2/22 A	9/4/23 A	8/1/24 A	8/12/25 A	9/1/26 A

¹INR in Million²INR

Estimates

Add to a list 0 selected To use this feature you must be a member Log in Sign up	P/E (Y)	EV / Sales (Y)	EV / EBITDA (Y)	Dividend Yield (Y)	Capi.($)
MOREPEN LABORATORIES LIMITED	-	-	-	-	665M
ELI LILLY AND COMPANY	31.77x	11.54x	23.41x	0.62%	994B
JOHNSON & JOHNSON	29.54x	-	-	2.02%	640B
ABBVIE INC.	32.92x	7.63x	15.78x	2.67%	454B
ROCHE HOLDING AG	18.71x	4.57x	11.31x	2.91%	337B
NOVARTIS AG	19.41x	5.08x	12.59x	3.23%	261B
ASTRAZENECA PLC	20.34x	4.19x	11.96x	2.11%	246B
AMGEN INC.	23.87x	6.3x	11.23x	2.67%	204B
NOVO NORDISK A/S	12.3x	4.48x	9.37x	4.08%	190B
GILEAD SCIENCES, INC.	-43.47x	6.35x	24.81x	2.29%	178B
Average	16.16x	6.27x	15.06x	2.51%	350.54B
Weighted average by Cap.	23.19x	7.72x	17.10x	2.05%